Cardiome Pharma Corp.

Details Cardiome Pharma Corp. Cardiome Pharma Corp.

www.cardiome.com

British Columbia

Vancouver

Vancouver

Corporation

active

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ National Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.
Country of Ownership: Canada
Year Established: 1992
Exporting: No
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Services
Number of Employees: 50

Products:
Rsd1235, Oxypurinol for allopurinol-intolerant gout, Kv1.5, Oxypurinol for chf

Technology:
Cardiome has developed particular skill and expertise in the
lead optimization of ion-channel modulating drugs. This strength
is embodied in three key resources which, within Cardiome, are
very well-integrated, resulting in fast lead-optimization: 1. Synthetic Chemistry
Cardiome's team of synthetic chemists have years of experience
in gram-scale synthesis of ion-channel modulating drugs.
2. Analytical Chemistry
Cardiome has equipment and full-time analytical staff to make
accurate analysis of drug substance concentration, enabling fast
determination of PK and ADME parameters.
3. In-Vivo and In-Vitro Bioassays
Cardiome has developed strong capability in the areas of in-
vitro cardiac pharmacological testing and in electrophysiology.
Operating in close concert, these skills enable rapid evolution
of lead molecules to clinical candidates.

Affiliated with

Also associated with

No associations

Rating

Cardiome Pharma Corp. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Cardiome Pharma Corp., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiome Pharma Corp. will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-COD-O-4775